APLLTD.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations...

Stats
Dagens volum	109 123
Gjennomsnittsvolum	173 633
Markedsverdi	195.94B
EPS	INR0 ( 2024-04-04 )
Neste inntjeningsdato	( INR6.90 ) 2024-05-08
Last Dividend	INR8.00 ( 2023-07-28 )
Next Dividend	INR0 ( N/A )
P/E	33.23
ATR14	INR1.154 (0.12%)

Volum Korrelasjon

Lang: -0.03 (neutral)

Kort: 0.37 (neutral)

Signal:(58.776) Neutral

Alembic Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
KRITIKA.NS	0.931
ICICIPHARM.NS	0.93
KOPRAN.NS	0.929
NAVNETEDUL.NS	0.923
MUTHOOTFIN.NS	0.921
STAR.NS	0.919
FAIRCHEMOR.NS	0.912
KCP.NS	0.908
AARTISURF.NS	0.907
20MICRONS.NS	0.907

10 Mest negative korrelasjoner
LTGILTBEES.NS	-0.938
4THDIM.NS	-0.936
RAJRILTD.NS	-0.93
JSL.NS	-0.893
ACI.NS	-0.864
GNA.NS	-0.858
SYMPHONY.NS	-0.853
ISMTLTD.NS	-0.849
DFMFOODS.NS	-0.834
GTNIND.NS	-0.817

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Alembic Pharmaceuticals Korrelasjon - Valuta/Råvare

-0.33
( neutral )

-0.29
( neutral )

-0.25
( neutral )

-0.36
( neutral )

-0.87
( strong negative )

0.52
( weak )

Alembic Pharmaceuticals Økonomi

Annual	2022
Omsetning:	INR56.53B
Bruttogevinst:	INR39.44B (69.77 %)
EPS:	INR17.40

FY	2022
Omsetning:	INR56.53B
Bruttogevinst:	INR39.44B (69.77 %)
EPS:	INR17.40

FY	2022
Omsetning:	INR52.32B
Bruttogevinst:	INR35.09B (67.06 %)
EPS:	INR26.50

FY	2021
Omsetning:	INR53.01B
Bruttogevinst:	INR37.80B (71.30 %)
EPS:	INR60.81

Financial Reports:

No articles found.

Alembic Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alembic Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.28 - low (9.11%) | Divividend Growth Potential Score: 3.88 - Decrease likely (22.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.400	2012-07-31
Last Dividend	INR8.00	2023-07-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	INR62.90	--
Avg. Dividend % Per Year	0.84%	--
Score	2.03	--
Div. Sustainability Score	3.28
Div.Growth Potential Score	3.88
Div. Directional Score	3.58	--

Next Divdend (Est)
(2024-06-27)

INR8.06 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR4.00	0.79%
2019	INR5.50	0.94%
2020	INR3.00	0.55%
2021	INR14.00	1.34%
2022	INR10.00	1.24%
2023	INR8.00	1.41%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SRF.NS	Dividend Junior	2023-08-01	Semi-Annually	21	0.25%
MRF.NS	Dividend Knight	2023-07-20	Semi-Annually	23	0.11%
HGINFRA.NS	Dividend Junior	2023-08-14	Sporadic	7	0.13%
BLISSGVS.NS	Dividend Junior	2023-07-12	Annually	15	0.46%
RBLBANK.NS	Dividend Junior	2023-08-18	Sporadic	8	0.25%
KOVAI.NS	Dividend Junior	2023-08-10	Annually	4	0.17%
EXIDEIND.NS	Dividend Junior	2023-08-01	Annually	22	0.76%
AMIORG.NS	Dividend Junior	2023-09-18	Annually	3	0.15%
TALBROAUTO.NS	Dividend Junior	2023-09-15	Annually	18	0.48%
NGIL.NS	No Dividend Player	2023-09-21	Annually	4	0.08%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0965	1.500	8.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.134	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	10.28	1.000	7.30	7.30	[3 - 30]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
freeCashFlowPerShareTTM	28.22	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.711	1.000	1.484	1.484	[0.2 - 0.8]
operatingProfitMarginTTM	0.100	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	33.64	1.000	6.70	0	[1 - 100]
returnOnEquityTTM	0.134	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.22	2.00	0.595	10.00	[0 - 30]
dividendYielPercentageTTM	0.792	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.643	1.500	9.05	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0907	1.000	-0.234	0	[0.1 - 0.5]
Total Score				3.88

Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.